compound glp 1 news New warning issued over compounded GLP-1 weight loss drugs Diabetes advocacy group discourages use

The brand specifically advises against these medications for people with: Personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome Type 2 A history of pancreatitis Type 1 diabetes The exact contraindications, warnings, and precautions vary by specific drug and should be reviewed in that medication's own FDA-approved prescribing information with a licensed clinician, not assumed to be identical across the whole GLP-1 class

Thats exactly why I want to walk you through how GLP-1s could work as a support to a more long-term PCOS treatment plan

Leaky gut and brain fog: Research supports that a leaky gut is a key component in autoimmunity, and a leaky gut is often associated with leaky brain and brain fog

In addition, less than 30% of patients remain on treatment for more than a year 6,7,8 , and treatment discontinuation typically results in rapid weight regain 4,9,10 , with the majority of this gain attributed to increases in fat mass 11,12,13

It activates GLP-1 receptors continuously at supraphysiological levels, which is why it produces dramatic weight loss results in clinical trials